[CYCC] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
14-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- 27.90%
YoY- 13.25%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 150 0 0 0 0 0 0 -
PBT -2,370 -2,369 -2,354 -1,531 -2,071 -2,076 -2,455 -2.31%
Tax -352 -301 -502 -182 -200 -219 -268 19.87%
NP -2,018 -2,068 -1,852 -1,349 -1,871 -1,857 -2,187 -5.20%
Tax Rate - - - - - - - -
Total Cost 2,168 2,068 1,852 1,349 1,871 1,857 2,187 -0.57%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin -1,345.33 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS -2.96 -3.45 -3.09 -2.25 -3.14 -3.78 -9.86 -55.06%
EPS Diluted -2.96 -3.45 -3.09 -2.25 -3.12 -3.78 -9.86 -55.06%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.